🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to evaluate the safety, tolerability and immunogenicity of a ...
Status
Completed
Location
Daido Clinic
Start Date
2018-07-12
Trial ID
NCT03571607
Treatments Being Tested
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00366899
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00452790
Treatments Being Tested
phase-1 study pneumococcal conjugate vaccine study in healthy adults...
Status
Unknown
Location
Multiple Locations
Start Date
2018-07-01
Trial ID
NCT03549208
Immune response analysis after the combination of PCV13 and PPV23 will lead...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-04
Trial ID
NCT02279589
Treatments Being Tested
Previous studies have demonstrated the immunogenicity and safety of the co-...
Status
Completed
Location
Korea University Ansan Hospital
Start Date
2012-10
Trial ID
NCT02582047
Treatments Being Tested
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
This study will evaluate the immunogenicity of a reduced dosing schedule of...
Status
Completed
Location
Chris Hani Baragwanath Academic Hospital
Start Date
2017-01-09
Trial ID
NCT02943902
Treatments Being Tested
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129